🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 2, multicenter, single-arm study with a safety lead-in to i...
Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Start Date
2022-06-02
Trial ID
NCT05195632
Treatments Being Tested
This ComboMATCH patient screening trial is the gateway to a coordinated set...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-04-07
Trial ID
NCT05564377
Treatments Being Tested
This phase I trial studies the MEK inhibitor MEK162 to see if it is safe in...
Status
Terminated
Location
Stanford University, School of Medicine
Start Date
2014-12
Trial ID
NCT02049801
Treatments Being Tested
This is a Phase 1 study during which patients with advanced solid tumors wi...
Status
Completed
Location
University of California, Los Angeles
Start Date
2009-08
Trial ID
NCT00959127
Treatments Being Tested
This phase II MATCH screening and multi-sub-trial studies how well treatmen...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2015-08-17
Trial ID
NCT02465060
Treatments Being Tested
This phase II trial studies intermittent dosing of BRAF inhibitor LGX818 (e...
Status
Withdrawn
Location
Jonsson Comprehensive Cancer Center
Start Date
2015-01
Trial ID
NCT02263898
Treatments Being Tested
This phase II trial studies how well binimetinib and palbociclib work compa...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2019-10-29
Trial ID
NCT03981614
Treatments Being Tested
This phase I trial studies the side effects and best dose of MEK inhibitor ...
Status
Completed
Location
City of Hope Medical Center
Start Date
2014-06
Trial ID
NCT02041481
This phase I trial tests the safety, side effects, and best dose of ZEN0036...
Status
Recruiting
Location
Boston Medical Center
Start Date
2022-08-02
Trial ID
NCT05111561
The main purpose of this study is to find out if the drugs MEK162 and erlot...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2013-12-30
Trial ID
NCT01859026